USP Joins in the Efforts to Stop Illegal Online Drug Sales - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

USP Joins in the Efforts to Stop Illegal Online Drug Sales


As part of a continuing mission to improve global health, the US Pharmacopeial Convention (USP) has joined with the Alliance for Safe Online Pharmacies (ASOP) to combat the threat posed by the illegal online sale of medicines.

Libby Baney, executive director of ASOP, emphasized that effectively confronting illegal online drug sellers requires collaboration by diverse stakeholders to protect patients worldwide.

Baney noted that according to the National Association of Boards of Pharmacy, at any one time there are approximately 40,000-50,000 active online drug sellers; nearly 97% do not comply with applicable laws and pharmacy practice standards, putting patients at risk. Ronald T. Piervincenzi, chief executive officer of USP, added that studies by the World Health Organization indicate that half of the drugs sold on some Internet sites are counterfeit.

Source: US Pharmacopeial Convention

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?

Click here